Bibliographic Details
| Title: |
Salvage treatment for primary resistant acute myelogenous leukemia consisting of intermediate-dose cytosine arabinoside and interspaced continuous infusions of idarubicin: a phase-II study (no. 06901) of the EORTC Leukemia Cooperative Group. |
| Authors: |
De Witte T; Department of Internal Medicine, University Hospital St. Radboud, Nijmegen, The Netherlands., Suciu S, Selleslag D, Labar B, Roozendaal K, Zittoun R, Ribeiro M, Kurstjens R, Hayat M, Dardenne M, Solbu G, Muus P |
| Source: |
Annals of hematology [Ann Hematol] 1996 Mar; Vol. 72 (3), pp. 119-24. |
| Publication Type: |
Clinical Trial; Clinical Trial, Phase II; Journal Article; Research Support, U.S. Gov't, P.H.S. |
| Journal Info: |
Publisher: Springer Verlag Country of Publication: Germany NLM ID: 9107334 Publication Model: Print Cited Medium: Print ISSN: 0939-5555 (Print) Linking ISSN: 09395555 NLM ISO Abbreviation: Ann Hematol Subsets: MEDLINE |
| Database: |
MEDLINE Ultimate |
